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CEREBRAL RADIONECROSIS WITH CYSTIC
DEGENERATION FOLLOWING RADIOTHERAPY FOR NASAL
CAVITY SQUAMOUS CELL CARCINOMA: A CASE REPORT
Ying-Che Hsu, Kuen-Yao Ho, Wen-Rei Kuo, Ling-Feng Wang,
Ka-Wo Lee, and Shiuh-Lin Huang1
Departments of Otolaryngology and 1Neurosurgery,
Kaohsiung Medical University, Kaohsiung, Taiwan.
A 31-year-old man with nasal cavity squamous cell carcinoma was treated in our hospital with two courses
of radiotherapy (120 Gy total dose) followed by surgical tumor resection. Three years after the last
irradiation, he developed seizures as well as changes in behavior and consciousness. Medical therapy with
diphenylhydantoin (Dilantin®) terminated the seizures. Dysphagia, unsteady gait, and right-side limb
weakness developed 37 months after the onset of seizures. Magnetic resonance imaging showed a
large, cystic mass in the left temporal lobe with left to right midline shift. Following craniotomy with
decompression of the cystic mass, the patient improved clinically. No malignant cells were found in the
specimen. No further progression of neurologic symptoms was noted after a 1-year follow-up. Cerebral
radionecrosis is an uncommon late complication of radiotherapy and needs to be differentiated from tumor
recurrence or metastasis if the irradiation field covers the cerebral region in patients with head and neck
malignancies.
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Malignant tumors of the sinonasal tract constitute less than
1% of all malignancies and about 3% of those arising in
the upper respiratory tract [1]. Treatment includes surgical
resection, radiotherapy, or a combination of both. Radio-
therapy is not without morbidity, and damage to the neigh-
boring structures may lead to long-term complications.
Delayed radionecrosis is rare and needs to be differentiated
from tumor metastasis or recurrence. Once malignant
disease has been excluded, initial conservative treatment
with corticosteroids has been suggested in many articles.
We report a rare case of cerebral cystic radionecrosis fol-
lowing radiotherapy for sinonasal tract malignancy.
CASE PRESENTATION
In June 1995, a 31-year-old male presented with the com-
plaints of painful nasal congestion, especially on the
left side, for 6 months, and blood-tinged sputum. A nasal
mass involving the anterior and middle parts of the nasal
septum and left inferior turbinate was biopsied at a local
hospital. Pathology was positive for poorly differentiated
squamous cell carcinoma, so the patient was referred to
our hospital for further evaluation and treatment. Treat-
ment was initiated with a total of 60 Gy of radiotherapy
administered from 3 July to 25 August 1995. A small portion
of normal brain was included within the two radiation
portals (anterior and left side). The tumor had a partial re-
sponse to radiation. The nasal septum and left inferior
turbinate were resected in September 1995.
Six months after surgery, outpatient biopsy demon-
strated recurrent tumor. The patient received another 60 Gy
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of radiotherapy followed by lateral rhinotomy with Den-
ker’s operation (medial maxillectomy). Regular follow-up
was unremarkable, without evidence of recurrent disease,
until November 1999.
At this time, there was sudden onset of seizures, beha-
vioral changes, and consciousness disturbances. Magnetic
resonance imaging (MRI) demonstrated bilateral digiti-
form lesions in the frontal and temporal lobes, especial-
ly in the left temporal lobe (Figure 1). Cerebral lesions
were thought to be secondary to radionecrosis. The patient
was treated with diphenylhydantoin (Dilantin®; Parke-
Davis Corp, Taoyuan, Taiwan) and ginkgo biloba extract
(Cerenin®; Dr Willmar Schwabe Co, Karlsruhe, Germany).
For the next 3 years during routine follow-up examinations,
the patient had only minor complaints of memory impair-
ment without any recurrence of seizures.
In December 2002, 37 months later, the patient developed
an unsteady gait with right-side weakness and experienced
memory loss and difficulties in speaking. MRI showed a
large cystic left temporal lobe mass with midline shift from
left to right (Figure 2). During craniotomy with decom-
pression of the cystic mass, yellowish fluid was found
within the cystic lesion. Pathology showed hemosiderin-
laden macrophages associated with reactive glial cells and
focal lymphoid tissue aggregated around sclerotic vessels.
No tumor cells were found. Neurologic symptoms subsided
after surgery and no further progression of neurologic
symptoms was seen after 1 year of follow-up.
DISCUSSION
Cerebral radionecrosis is a late complication of radiotherapy,
and the reported latency period from the end of radiotherapy
to the time of diagnosis ranges from 3 months to 19 years in
extracranial malignancies [2]. Clinical symptoms vary and
may include major symptoms such as consciousness chang-
es and seizures, as well as minor complaints of vertigo,
headache, or memory impairment. If a patient has neurolo-
gic or psychiatric symptoms following radiation, delayed
radiation encephalopathy or brain metastases should be
considered. Several authors have emphasized that, if left
untreated, delayed cerebral radionecrosis is usually ir-
reversible, progressive, and often fatal [3,4].
In our case, a radiotherapist administered a total of
120 Gy within a 12-month period in two divided 60 Gy
doses, each delivered in 30 fractions over 42 days. Our
patient received a much higher radiation dose than is
normally administered because of the need for irradia-
tion for tumor recurrence. The radiotherapy portal lower
limit for the nasal cavity was set just below the level of
the zygoma and the upper limit could have included
a portion of the temporal lobe.
A 60 Gy dose delivered in 1.8–2.0 Gy fractions repre-
sents the upper limit of the safe dose of irradiation to brain
tissue [5]. If the dose exceeds the limit, the incidence of
radionecrosis increases. In 1984, Glass et al reported nine
cases of cerebral radionecrosis with extracranial malig-
nancies and reviewed another 65 cases in the literature [6].
Only 14 sinonasal malignancies developed cerebral radio-
necrosis, and few cases have been reported otherwise. Out
of a total of 74 cases of cerebral radionecrosis, 36 of 68 (53%)
reviewed cases received a radiation dose of more than
60 Gy; the remaining six cases were not included as the
dosage was unknown. Hawkins et al reported their results
with primary and adjuvant radiotherapy for nasal cavity
carcinoma [7]. Twenty-three of 56 (41%) cases received
more than 65 Gy; however, no patient developed cerebral
radionecrosis. The exact incidence of cerebral radionecrosis
Figure 1. Magnetic resonance image shows a digitiform hyperintense
lesion at bilateral frontotemporal lobes with interposed irregular en-
hancement after contrast administration.
Figure 2. Magnetic resonance image 37 months later. The brain paren-
chyma, left thalamus, and basal ganglion are displaced to the right, and
the left lateral ventricle is severely compressed.
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in extracranial malignancies is not clear because it occurs
sporadically and depends on tumor location and type.
Lee et al reported the incidence of cerebral radionecrosis
following nasopharyngeal carcinoma as 1.03% in a large
series [8]. In another study of 1,008 consecutive patients
with nasopharyngeal carcinoma who were treated with
radiotherapy, 74 patients had a clinical diagnosis of tem-
poral lobe radionecrosis. Analysis of irradiation regimens
led them to conclude that fractional dose was the most
important factor causing late radiation necrosis, and that
prolonging the treatment time offered little protective
effect [9]. Lee et al estimated that 64 Gy at the conven-
tional fractional dose of 2 Gy daily would result in a
5% necrotic rate after 10 years [9].
The most commonly accepted etiology of cerebral
radionecrosis is radiation-induced endothelial cell damage
followed by long-term ischemic changes in affected cere-
bral tissue [10]. The gold standard for diagnosis of radia-
tion necrosis is pathologic proof by surgical exploration or
autopsy. However, a clinical diagnosis can be made with-
out pathology, and imaging findings of radionecrosis have
been discussed in the literature. Computed tomography
(CT) can show digitiform or round hypodense lesions. On
MRI images, radionecrosis manifests as low signal areas in
T1-weighted and high-signal areas in T2-weighted images,
with irregular or cystic shapes. MRI is superior to CT in
sensitivity, and lesions are best shown on T2-weighted
scans [11]. Differentiation of radionecrosis from tumor is
difficult based on CT or MRI findings alone because both
lesions have similar imaging characteristics and can show
contrast enhancement. Scintigraphic studies such as 18F-
fluorodeoxyglucose positron emission tomography (FDG-
PET) and 201Tl chloride single-photon emission CT (SPECT)
can distinguish tumor from radionecrosis, and both
techniques are sensitive to tumor recurrence [12]. There
are no significant differences in sensitivity or specificity
for FDG-PET and 201Tl SPECT, and either can provide im-
portant diagnostic information.
MRI findings in our patient in November 1999 showed
a digitiform hyperintense lesion in bilateral frontotemporal
lobes, with interposed irregular enhancement after contrast
administration, and these findings need to be differentiated
from tumor recurrence. In this case, there was no evidence
of metastatic disease elsewhere in the body or in the brain.
Fiberscopic examination with repeat nasal cavity biopsy
was negative for tumor. All changes in the base of the skull
and the nasal cavity seen on imaging studies were consistent
with postsurgical changes without osseous destruction or
other obvious evidence of recurrent neoplasm.
Although treatment of cerebral radionecrosis includes
surgical exploration, such as necrotomy and cerebral
lobectomy, medical therapy with corticosteroids is more
often recommended in the recent literature. Studies have
reported using 4–16 mg of dexamethasone daily for 4 to 6
weeks, and gradually tapering the dose over the next 2
months [8,13]. The changes of radionecrosis are irrever-
sible, although some effects caused by pressure or edema
can be relieved by surgical decompression or corticosteroid
treatment. In our case, we found that the disease progressed
slowly over several years without corticosteroid treatment.
However, long-term use of corticosteroids for cerebral radio-
necrosis is not without significant risks. Lee et al re-
ported that 44% of cerebral radionecrosis patients on
corticosteroids experienced associated side effects, and
that the mortality rate was 8% due to uncontrolled sep-
sis [8]. In addition, the use of corticosteroids is a predis-
posing factor for brain abscess formation in patients with
cerebral necrotic tissue [14]. Lee et al also used MRI to
survey temporal lobe radionecrosis in patients with naso-
pharyngeal carcinoma. They assumed that irregular le-
sions consisted mainly of reactive white matter edema, and
that rounded lesions were mainly central liquefactive
necrosis with surrounding gliosis [11]. Only patients with
marked reactive edema and minimal liquefactive necrosis
were likely to show a durable objective response to conser-
vative treatment with corticosteroids [11]. In our experience,
an obviously liquefactive lesion with mass effect should be
treated with surgical intent, followed by postoperative cor-
ticosteroids. Mildly symptomatic or asymptomatic patients
can be initially treated with corticosteroids.
REFERENCES
1. Carrau RL, Myers EN. Neoplasms of the nose and paranasal
sinuses. In: Bailey BJ, Calhoun KH, Healy GB, et al (eds). Head
& Neck Surgery – Otolaryngology, 3rd edition. Philadelphia:
Lippincott Williams & Wilkins, 2001:1247–65.
2. Chandler A, Tucker FC, Herzberger EE. Late radiation necrosis
of the brain. Wis Med J 1964;63:297–300.
3. De Reuck J, vander Eecken H. The anatomy of late radiation
encephalopathy. Eur Neurol 1975;13:481–94.
4. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and
brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215–28.
5. Keime-Guibert F, Napolitano M, Delattre JY. Neurologic
complications of radiotherapy and chemotherapy. J Neurol
1998;245:695–708.
6. Glass JP, Hwang TL, Leavens ME, Libshitz HI. Cerebral radia-
tion necrosis following treatment of extracranial malignancies.
Cancer 1984;54:1966–72.
Radiotherapy-induced cerebral radionecrosis
311Kaohsiung J Med Sci June 2004 • Vol 20 • No 6
7. Hawkins RB, Wynstra JH, Pilepich MV, Fields JN. Carcinoma
of the nasal cavity – results of primary and adjuvant radio-
therapy. Int J Radiat Oncol Biol Phys 1988;15:1129–33.
8. Lee AW, Ng SH, Ho JH, et al. Clinical diagnosis of late tem-
poral lobe necrosis following radiation therapy for nasopharyn-
geal carcinoma. Cancer 1988;61:1535–42.
9. Lee AW, Foo W, Chappell R, et al. Effect of time, dose, and
fractionation on temporal lobe necrosis following radiotherapy
for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys
1998;40:35–42.
10. Conomy JP, Kellermeyer RW. Delayed cerebrovascular conse-
quences of therapeutic radiation. A clinicopathologic study of
a stroke associated with radiation-related carotid arteriopathy.
Cancer 1975;26:1702–8.
11. Lee AW, Cheng LO, Ng SH, et al. Magnetic resonance imaging
in the clinical diagnosis of late temporal lobe necrosis following
radiotherapy for nasopharyngeal carcinoma. Clin Radiol 1990;
42:24–31.
12. Kahn D, Follet KA, Bushnell DL, et al. Diagnosis of recurrent
brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose
PET. AJR Am J Roentgenol 1994;163:1459–65.
13. Shaw PJ, Bates D. Conservative treatment of delayed cere-
bral radiation necrosis. J Neurol Neurosurg Psychiatry 1984;47:
1338–41.
14. Chen KM, Chan CM, Fu YT, et al. Brain abscess formation in
radiation necrosis of the temporal lobe following radiation
therapy for nasopharyngeal carcinoma. Acta Neurochir (Wien)
2000;142:435–41.
Kaohsiung J Med Sci June 2004 • Vol 20 • No 6
Y.C. Hsu, K.Y. Ho, W.R. Kuo, et al
312
®
